Biomedical Engineering Reference
In-Depth Information
[19] Fraser TS, Kappe SH, NarumDL, VanBuskirk KM, Adams JH. Erythrocyte-binding activity
of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected
COS-7 cells. Mol Biochem Parasitol 2001;117:49-59.
[20] Kato K, Mayer DC, Singh S, Reid M, Miller LH. Domain III of Plasmodium falciparum
apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. Proc Natl Acad
Sci USA 2005;102:5552-5557.
[21] Dicko A, Diemert DJ, Sagara I, SogobaM, NiambeleMB, AssadouMH, GuindoO, Kamate B,
BabyM, SissokoM,MalkinEM, FayMP, TheraMA,MiuraK, DoloA, DialloDA,MullenGE,
Long CA, Saul A, Doumbo O, Miller LH. Impact of a Plasmodium falciparumAMA1 vaccine
on antibody responses in adult malians. PLoS ONE 2007;2:e1045.
[22] Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, Giersing BK, Mullen GE,
Orcutt A, Muratova O, Awkal M, Zhou H, Wang J, Stowers A, Long CA, Mahanty S, Miller
LH, Saul A, Durbin AP. Phase 1 clinical trial of apical membrane antigen 1: an asexual
blood-stage vaccine for Plasmodium falciparummalaria. Infect Immun 2005;73:3677-3685.
[23] WuY, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, FayMP, NarumD, RauschKM,
Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul
A, Miller LH, Durbin AP. Phase 1 Trial of Malaria Transmission Blocking Vaccine
Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51. PLoS ONE 2008;3 (8):
e2940. http://www.plosone.org/doi/pone.0002636.
[24] Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson
KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S,
Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J,
Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph
SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ,
Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B. Genome sequence of the human
malaria parasite Plasmodium falciparum. Nature 2002;419:498-511.
[25] Liang H, Narum DL, Dey C, Chang A, Fuhrmann SR, Luu T, Sim BKL. Recombinant
expression and characterization of EBA-175 receptor binding domain in Pichia pastoris.
Program and Abstracts of the 48th Annual Meeting of the American Society of Tropical
Medicine and Hygiene; 1999, Vol. 61. Abstract.
[26] Scorer CA, Buckholz RG, Clare JJ, Romanos MA. The intracellular production and
secretion of HIV-1 envelope protein in the methylotrophic yeast. Pichia pastoris. Gene
1993;136:111-119.
[27] KockenCH, van derWel AM, DubbeldMA, NarumDL, van de Rijke FM, vanGemert GJ, van
der Linde X, Bannister LH, Janse C,Waters AP, Thomas AW. Precise timing of expression of a
Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of
subsequent subcellular localization. J Biol Chem 1998;273:15119-15124.
[28] Ikemura T. Codon usage and tRNA content in unicellular and multicellular organisms. Mol
Biol Evol 1985;2:13-34.
[29] Narum DL, Kumar S, Rogers WO, Fuhrmann SR, Liang H, Oakley M, Taye A, Sim BK,
Hoffman SL. Codon optimization of gene fragments encoding Plasmodium falciparum
merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
Infect Immun 2001;69:7250-7253.
[30] Kennedy MC, Wang J, Zhang Y, Miles AP, Chitsaz F, Saul A, Long CA, Miller LH, Stowers
AW. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1
(AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic
response. Infect Immun 2002;70:6948-6960.
